Ramadan intermittent fasting reduces visceral fat and improves gastrointestinal motility.
Ramadan
gastrointestinal motility
gastrointestinal symptoms
metabolic homeostasis
ultrasonography
visceral fat
Journal
European journal of clinical investigation
ISSN: 1365-2362
Titre abrégé: Eur J Clin Invest
Pays: England
ID NLM: 0245331
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
revised:
10
05
2023
received:
25
04
2023
accepted:
10
05
2023
medline:
21
8
2023
pubmed:
19
5
2023
entrez:
19
5
2023
Statut:
ppublish
Résumé
Ramadan is a model of intermittent fasting linked with possible beneficial effects. Scarce information, however, is available about the combined effects of Ramadan intermittent fasting (RIF) on anthropometric and metabolic indices, gastrointestinal symptoms, and motility. In 21 healthy Muslims, we assessed the impact of RIF on caloric intake, physical activity, gastrointestinal symptoms and motility (gastric/gallbladder emptying by ultrasonography, orocaecal transit time by lactulose breath test), anthropometric indices, subcutaneous and visceral fat thickness (ultrasonography), glucose and lipid homeostasis. Mean caloric intake decreased from a median of 2069 kcal (range 1677-2641) before Ramadan to 1798 kcal (1289-3126) during Ramadan and increased again to 2000 kcal (1309-3485) after Ramadan. Although physical activity remained stable before, during, and after RIF, body weight, body mass index and waist circumference decreased in all subjects and in both genders, together with a significant decrease in subcutaneous and visceral fat thickness and insulin resistance. The postprandial gastric emptying speed was significantly faster after than before RIF. Fasting gallbladder volume was about 6% smaller after, than before Ramadan, with a stronger and faster postprandial gallbladder contraction. After RIF, lactulose breath test documented increased microbiota carbohydrate fermentation (postprandial H RIF generates, in healthy subjects, multiple systemic beneficial effects in terms of fat burden, metabolic profile, gastrointestinal motility and symptoms. Further comprehensive studies should assess the potential beneficial effects of RIF in diseased people.
Sections du résumé
BACKGROUND
BACKGROUND
Ramadan is a model of intermittent fasting linked with possible beneficial effects. Scarce information, however, is available about the combined effects of Ramadan intermittent fasting (RIF) on anthropometric and metabolic indices, gastrointestinal symptoms, and motility.
METHODS
METHODS
In 21 healthy Muslims, we assessed the impact of RIF on caloric intake, physical activity, gastrointestinal symptoms and motility (gastric/gallbladder emptying by ultrasonography, orocaecal transit time by lactulose breath test), anthropometric indices, subcutaneous and visceral fat thickness (ultrasonography), glucose and lipid homeostasis.
RESULTS
RESULTS
Mean caloric intake decreased from a median of 2069 kcal (range 1677-2641) before Ramadan to 1798 kcal (1289-3126) during Ramadan and increased again to 2000 kcal (1309-3485) after Ramadan. Although physical activity remained stable before, during, and after RIF, body weight, body mass index and waist circumference decreased in all subjects and in both genders, together with a significant decrease in subcutaneous and visceral fat thickness and insulin resistance. The postprandial gastric emptying speed was significantly faster after than before RIF. Fasting gallbladder volume was about 6% smaller after, than before Ramadan, with a stronger and faster postprandial gallbladder contraction. After RIF, lactulose breath test documented increased microbiota carbohydrate fermentation (postprandial H
CONCLUSIONS
CONCLUSIONS
RIF generates, in healthy subjects, multiple systemic beneficial effects in terms of fat burden, metabolic profile, gastrointestinal motility and symptoms. Further comprehensive studies should assess the potential beneficial effects of RIF in diseased people.
Substances chimiques
Lactulose
4618-18-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14029Subventions
Organisme : Horizon 2020 Framework Programme
ID : 722619
Organisme : Horizon 2020 Framework Programme
ID : 734719
Organisme : Regione Puglia
ID : CUP H99C20000340002
Organisme : Universita degli Studi di Bari Aldo Moro
ID : EUROSEEDS Uniba - S56
Informations de copyright
© 2023 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Références
van Ewijk RJ, Painter RC, Roseboom TJ. Associations of prenatal exposure to Ramadan with small stature and thinness in adulthood: results from a large Indonesian population-based study. Am J Epidemiol. 2013;177:729-736.
Faris AE, Jahrami HA, Alsibai J, Obaideen AA. Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis. Br J Nutr. 2020;123:1-22.
Jahrami H, Trabelsi K, Alhaj OA, Saif Z, Pandi-Perumal SR, BaHammam AS. The impact of Ramadan fasting on the metabolic syndrome severity in relation to ethnicity and sex: results of a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32:2714-2729.
Faris MA, Kacimi S, Al-Kurd RA, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012;32:947-955.
Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Investig. 2010;40:35-53.
Molina-Molina E, Shanmugam H, Di Ciaula A, et al. ((13)C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Rep. 2021;3:100203.
Shanmugam H, Molina Molina E, Di Palo DM, et al. Physical activity modulating lipid metabolism in gallbladder diseases. J Gastrointestin Liver Dis. 2020;29:99-110.
Shanmugam H, Di Ciaula A, Di Palo DM, et al. Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. Eur J Clin Investig. 2021;51:e13597.
Di Ciaula A, Covelli M, Berardino M, et al. Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol. 2008;8:7.
Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol. 1996;143:228-239.
Gnatiuc L, Alegre-Diaz J, Wade R, et al. General and abdominal adiposity and mortality in Mexico City: a prospective study of 150 000 adults. Ann Intern Med. 2019;171:397-405.
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129:S102-S138.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
Di Ciaula A, Grattagliano I, Portincasa P. Chronic alcoholics retain dyspeptic symptoms, pan-enteric dysmotility, and autonomic neuropathy before and after abstinence. J Dig Dis. 2016;17:735-746.
Portincasa P, Colecchia A, Di Ciaula A, et al. Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo Italiano di studio Motilita Apparato Digerente. Dig Liver Dis. 2000;32:160-172.
Caponio GR, Lorusso MP, Sorrenti GT, et al. Chemical characterization, gastrointestinal motility and sensory evaluation of dark chocolate: a nutraceutical boosting Consumers' health. Nutrients. 2020;12:939.
Portincasa P, Moschetta A, Berardino M, et al. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol. 2004;10:2383-2390.
Hintze J. NCSS Statistical Software (2023). NCSS, LLC. Kaysville, Utah, USA, Kaysville, Utah: NUMBER Cruncher Statistical System (NCSS); 2023. 2023 ncss.com/software/ncss.
Bass J, Lazar MA. Circadian time signatures of fitness and disease. Science. 2016;354:994-999.
Nørrelund H. The metabolic role of growth hormone in humans with particular reference to fasting. Growth Hormon IGF Res. 2005;2:95-122.
Stockman MC, Thomas D, Burke J, Apovian CM. Intermittent fasting: is the wait worth the weight? Curr Obes Rep. 2018;7:172-185.
St-Onge M-P, Ard J, Baskin ML, et al. Meal timing and frequency: implications for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2017;135:e96-e121.
Collier R. Intermittent fasting: the science of going without. CMAJ. 2013;185:E363-E364.
Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90:1138-1143.
Lamri-Senhadji M, El Kebir B, Belleville J, Bouchenak M. Assessment of dietary consumption and time-course of changes in serum lipids and lipoproteins before, during and after Ramadan in young Algerian adults. Singap Med J. 2009;50:288-294.
Ziaee V, Razaei M, Ahmadinejad Z, et al. The changes of metabolic profile and weight during Ramadan fasting. Singap Med J. 2006;47:409-414.
Arab M. Ketonuria and serum glucose of fasting pregnant women at the end of a day in Ramadan. Acta Med Iran. 2004;42:209-212.
Sweileh N, Schnitzler A, Hunter GR, Davis B. Body composition and energy metabolism in resting and exercising muslims during Ramadan fast. J Sports Med Phys Fitness. 1992;32:156-163.
Ennigrou S, Zenaidi M, Ben Slama F, Zouari B, Nacef T. Ramadan and customs of life: investigation with 84 adult residents in the district of Tunis. Tunis Med. 2001;79:508-514.
Afifi ZE. Daily practices, study performance and health during the Ramadan fast. J R Soc Health. 1997;117:231-235.
Kalam F, Akasheh RT, Cienfuegos S, et al. Effect of time-restricted eating on sex hormone levels in premenopausal and postmenopausal females. Obesity (Silver Spring). 2023;31(Suppl 1):57-62.
Cienfuegos S, Corapi S, Gabel K, et al. Effect of intermittent fasting on reproductive hormone levels in females and males: a review of human trials. Nutrients. 2022;14:2343.
Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005;81:69-73.
Varady KA, Bhutani S, Klempel MC, et al. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013;12:146.
Trepanowski JF, Kroeger CM, Barnosky A, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and Cardioprotection among metabolically healthy obese adults: a randomized clinical trial. JAMA Intern Med. 2017;177:930-938.
Longo VD, Panda S. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab. 2016;23:1048-1059.
Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Intern Med. 2020;180:1491-1499.
Liu D, Huang Y, Huang C, et al. Calorie restriction with or without time-restricted eating in weight loss. N Engl J Med. 2022;386:1495-1504.
Perdomo CM, Cohen RV, Sumithran P, Clement K, Fruhbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401:1116-1130.
Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35:714-727.
Eshghinia S, Mohammadzadeh F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabetes Metab Disord. 2013;12:1-4.
Harvie M, Wright C, Pegington M, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013;110:1534-1547.
Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007;42:665-674.
Wegman MP, Guo MH, Bennion DM, et al. Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolism. Rejuvenation Res. 2015;18:162-172.
Heilbronn LK, Civitarese AE, Bogacka I, Smith SR, Hulver M, Ravussin E. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res. 2005;13:574-581.
Halberg N, Henriksen M, Soderhamn N, et al. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 1985;2005(99):2128-2136.
Soeters MR, Lammers NM, Dubbelhuis PF, et al. Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism. Am J Clin Nutr. 2009;90:1244-1251.
Trepanowski JF, Kroeger CM, Barnosky A, et al. Effects of alternate-day fasting or daily calorie restriction on body composition, fat distribution, and circulating adipokines: secondary analysis of a randomized controlled trial. Clin Nutr. 2018;37:1871-1878.
Antoni R, Johnston KL, Collins AL, Robertson MD. Investigation into the acute effects of total and partial energy restriction on postprandial metabolism among overweight/obese participants. Br J Nutr. 2016;115:951-959.
Horne BD, Muhlestein JB, May HT, et al. Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiography. Am J Cardiol. 2012;109:1558-1562.
Youm Y-H, Nguyen KY, Grant RW, et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21:263-269.
Ristow M, Schmeisser K. Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose-Response. 2014;12:288-341.
Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest. 2010;120:3466-3479.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-2023.
Portincasa P. NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care. Intern Emerg Med. 2023;18:961.
Beckmann APS, Gama LA, Machado MPR, Alves WDL, Cora LA, Americo MF. Alternate-day fasting induces metabolic and morphofunctional changes in the gastrointestinal tract of male rats. Appl Physiol Nutr Metab. 2023 doi:10.1139/apnm-2022-0356. Online ahead of print.
Di Ciaula A, Wang DQ, Portincasa P. Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol. 2012;27:1298-1305.
Kaya SD, Sinen O, Bulbul M. Gastric motor dysfunction coincides with the onset of obesity in rats fed with high-fat diet. Clin Exp Pharmacol Physiol. 2021;48:553-562.
Di Ciaula A, Garruti G, Lunardi Baccetto R, et al. Bile acid physiology. Ann Hepatol. 2017;16:s4-s14.
Dhillo WS, Bloom SR. Gastrointestinal hormones and regulation of food intake. Horm Metab Res. 2004;36:846-851.
Zouhal H, Bagheri R, Triki R, et al. Effects of Ramadan intermittent fasting on gut hormones and body composition in males with obesity. Int J Environ Res Public Health. 2020;17:5600.
Li G, Xie C, Lu S, et al. Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota. Cell Metab. 2017;26(4):672-685.e4.
Perez-Gerdel T, Camargo M, Alvarado M, Ramirez JD. Impact of intermittent fasting on the gut microbiota: a systematic review. Adv Biol (Weinh). 2023;e2200337. doi:10.1002/adbi.202200337. Online ahead of print.
NasrAllah MM, Osman NA. Fasting during the month of Ramadan among patients with chronic kidney disease: renal and cardiovascular outcomes. Clin Kidney J. 2014;7:348-353.